{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T15:37:47Z","timestamp":1792337867465,"version":"4.4.0"},"reference-count":19,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2014,11,20]],"date-time":"2014-11-20T00:00:00Z","timestamp":1416441600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0003333","type":"journal-article","created":{"date-parts":[[2014,11,20]],"date-time":"2014-11-20T19:06:56Z","timestamp":1416510416000},"page":"e3333","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":35,"title":["Assessing Progress in Reducing the At-Risk Population after 13 Years of the Global Programme to Eliminate Lymphatic Filariasis"],"prefix":"10.1371","volume":"8","author":[{"given":"Pamela J.","family":"Hooper","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian K.","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexei","family":"Mikhailov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric A.","family":"Ottesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Bradley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,11,20]]},"reference":[{"key":"ref1","first-page":"389","article-title":"Global programme to eliminate lymphatic filariasis: progress report for 2012","volume":"88","year":"2013","journal-title":"Weekly epidemiological record"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1017\/S0031182000066646","article-title":"Re-assessing the global prevalence and distribution of lymphatic filariasis","volume":"112","author":"E Michael","year":"1996","journal-title":"Parasitology"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1046\/j.1365-3156.2000.00620.x","article-title":"The global programme to eliminate lymphatic filariasis","volume":"5","author":"EA Ottesen","year":"2000","journal-title":"Trop Med Int Health"},{"key":"ref4","unstructured":"World Health Organization WHO Preventive Chemotherapy Databank."},{"key":"ref5","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/2049-9957-2-30","article-title":"The history of the elimination of lymphatic filariasis in China","volume":"2","author":"S De-Jian","year":"2013","journal-title":"Infect Dis Poverty"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1179\/000349802125002374","article-title":"Lymphatic filariasis elimination: progress in global programme development","volume":"96","author":"DH Molyneux","year":"2002","journal-title":"Ann Trop Med Parasitol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/S0140-6736(06)68426-2","article-title":"Effect of yearly mass drug administration with diethylcarbamazine and albendazole on bancroftian filariasis in Egypt: a comprehensive assessment","volume":"367","author":"RM Ramzy","year":"2006","journal-title":"Lancet"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1056\/NEJMoa021309","article-title":"Mass treatment to eliminate filariasis in Papua New Guinea","volume":"347","author":"MJ Bockarie","year":"2002","journal-title":"N Engl J Med"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1046\/j.1365-3156.2000.00661.x","article-title":"Elimination of bancroftian filariasis (Wuchereria bancrofti) in Santa Catarina state, Brazil","volume":"5","author":"BR Schlemper Jr","year":"2000","journal-title":"Trop Med Int Health"},{"key":"ref10","first-page":"172","article-title":"Towards eliminating lymphatic filariasis in Papua New Guinea: impact of annual single-dose mass treatment on transmission of Wuchereria bancrofti in East Sepik Province","volume":"43","author":"MJ Bockarie","year":"2000","journal-title":"P N G Med J"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/S0035-9203(01)90260-3","article-title":"Placebo-controlled community trial of four cycles of single-dose diethylcarbamazine or ivermectin against Wuchereria bancrofti infection and transmission in India","volume":"95","author":"PK Das","year":"2001","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref12","first-page":"769","article-title":"Long-term efficacy of single-dose mass treatment with diethylcarbamazine citrate against diurnally subperiodic Wuchereria bancrofti: eight years' experience in Samoa","volume":"70","author":"E Kimura","year":"1992","journal-title":"Bull World Health Organ"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1179\/136485905X19838","article-title":"Significant decrease in the prevalence of Wuchereria bancrofti infection in anopheline mosquitoes following the addition of albendazole to annual, ivermectin-based, mass treatments in Nigeria","volume":"99","author":"FO Richards Jr","year":"2005","journal-title":"Ann Trop Med Parasitol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"608","DOI":"10.3201\/eid1304.061063","article-title":"Endpoints for lymphatic filariasis programs","volume":"13","author":"CA Grady","year":"2007","journal-title":"Emerg Infect Dis"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"e317","DOI":"10.1371\/journal.pntd.0000317","article-title":"The global programme to eliminate lymphatic filariasis: health impact after 8 years","volume":"2","author":"EA Ottesen","year":"2008","journal-title":"PLoS Negl Trop Dis"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"e708","DOI":"10.1371\/journal.pntd.0000708","article-title":"The economic benefits resulting from the first 8 years of the Global Programme to Eliminate Lymphatic Filariasis (2000\u20132007)","volume":"4","author":"BK Chu","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"key":"ref17","unstructured":"World Health Organization (2011) Monitoring and epidemiological assessment of mass drug administration in the global programme to eliminate lymphatic filariasis: a manual for national elimination programmes. Geneva, Switzerland."},{"key":"ref18","unstructured":"Ramaiah KD, Ottesen EA (In press) Progress and impact of the Global Programme to Eliminate Lymphatic Filariasis through mass drug administration. PLoS Negl Trop Dis."},{"key":"ref19","unstructured":"World Health Organization (2010) Progress report 2000\u20132010 and Strategic plan 2010\u20132020 of the Global Programme to Eliminate Lymphatic Filariasis: halfway towards eliminating lymphatic filariasis. Geneva, Switzerland: World Health Organization, 78 p."}],"container-title":["PLoS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0003333","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T06:15:08Z","timestamp":1589004908000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0003333"}},"subtitle":[],"editor":[{"given":"Dunstan","family":"Mukoko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,11,20]]},"references-count":19,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2014,11,20]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0003333","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,20]]}}}